Targeting BRD4 in acute myeloid leukemia with partial tandem duplication of the <i>MLL</i> gene

• Marius Bill,
• Chinmayee Goda,
• Felice Pepe,
• Hatice Gulcin Ozer,
• Betina McNeil,
• Xiaoli Zhang,
• Malith Karunasiri,
• Rohan Kulkarni,
• Sonu Kalyan,
• Dimitrios Papaioannou,
• Gregory Ferenchak,
• Ramiro Garzon,
• James E. Bradner,
• Guido Marcucci,
• Michael A. Caligiuri,
• Adrienne M. Dorrance

Affiliations

Marius Bill

The Ohio State University, Comprehensive Cancer Center, Columbus, OH, USA; Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus Dresden, Dresden

Chinmayee Goda

The Ohio State University, Comprehensive Cancer Center, Columbus, OH

Felice Pepe

The Ohio State University, Comprehensive Cancer Center, Columbus, OH

Hatice Gulcin Ozer

The Ohio State University, Department of Biomedical Informatics, Columbus, OH

Betina McNeil

The Ohio State University, Comprehensive Cancer Center, Columbus, OH

Xiaoli Zhang

The Ohio State University, Department of Biomedical Informatics, Columbus, OH

Malith Karunasiri

The Ohio State University, Comprehensive Cancer Center, Columbus, OH

Rohan Kulkarni

The Ohio State University, Comprehensive Cancer Center, Columbus, OH

Sonu Kalyan

The Ohio State University, Comprehensive Cancer Center, Columbus, OH

Dimitrios Papaioannou

The Ohio State University, Comprehensive Cancer Center, Columbus, OH, USA; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH

Gregory Ferenchak

The Ohio State University, Comprehensive Cancer Center, Columbus, OH

Ramiro Garzon

The Ohio State University, Comprehensive Cancer Center, Columbus, OH, USA; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH

James E. Bradner

Dana-Faber Cancer Institute, Boston, MA

Guido Marcucci

City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA 91010

Michael A. Caligiuri

City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA 91010

Adrienne M. Dorrance

The Ohio State University, Comprehensive Cancer Center, Columbus, OH, USA; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH